Mizuho’s Jared Holz on why he is bullish on biotech heading into 2026
Jared Holz, Mizuho, joins 'Power Lunch' to talk how to play healthcare and biotech moving into 2026. source
Jared Holz, Mizuho, joins 'Power Lunch' to talk how to play healthcare and biotech moving into 2026. source
Jared Holz, Mizuho, joins 'Fast Money' to talk Novo Nordisk shares sliding on latest drug trial and how to treat ...
Jared Holz, Mizuho, joins 'Closing Bell Overtime' to discuss if the biotech sector is ready for a breakout. source
Dan Dolev, Mizuho senior financial technology analyst, joins 'Power Lunch' to discuss Circle's performance post-IPO. source
Jared Holz, Mizuho, joins 'Fast Money' to talk stock movement in the healthcare space on Roche's oral GLP-1 data. For ...
"This Federal Reserve has been itching to cut rates," Mizuho Securities US Chief Economist Steven Ricchiuto says on Bloomberg Television. ...
Copyright © 2024 Defi Daily.
Defi Daily is not responsible for the content of external sites.
Copyright © 2024 Defi Daily.
Defi Daily is not responsible for the content of external sites.